Our blog pages deal with all aspects of drug development.
Our emphasis is on new drugs in the pipeline.

Views expressed are based on published literature and my understanding of the scientific, regulatory and commercial context.

Please contact us if you detect any factual errors – we are keen to learn and correct them.  Your feed-back is most welcome!

Information and opinions are provided without commercial bias and based on published information only.

This site does not accept advertising or promotional content and will always defend its staunchly independent character